Adi Gilboa-Geffen

Adi Gilboa-Geffen's work experience includes senior leadership roles in product R&D at Eleven Therapeutics and advisor, co-founder, and chief scientific officer at DOTS Technology Corp. They were also a board member at DOTS Technology Corp from 2014 to 2021. Additionally, they worked as a research fellow at Harvard Medical School from 2011 to 2014 and as a Federation of Biochemical Societies research fellow at Bonn University from 2010 to 2011. Before that, they served as a scientific consultant at Yissum Research Development Company of the Hebrew University from 2009 to 2011. Adi Gilboa-Geffen began their career as a lieutenant in the navy of the Israel Defense Forces from 1995 to 1998.

Adi Gilboa-Geffen has a diverse education history. They began their academic journey by studying Law at The Hebrew University of Jerusalem. However, it is unclear when they pursued this subject or if they completed a degree in Law.

Following their interest in Law, Adi turned their focus towards the field of Biology, Neurobiology, and Psychology. From 2000 to 2004, they attended The Hebrew University of Jerusalem and obtained both a BSc and an MSc degree in these areas.

Adi further pursued their passion for Biological Chemistry. They enrolled at The Hebrew University of Jerusalem once again, where they completed their PhD from 2005 to 2010.

In addition to their studies in Biological Chemistry, Adi also explored Immunology at the prestigious Harvard Medical School. However, the duration of their study in this field is unknown.

Overall, Adi Gilboa-Geffen holds a range of qualifications in various scientific disciplines, including Biology, Neurobiology, Psychology, Biological Chemistry, and potentially Immunology.